TRICARICO, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 11.850
AS - Asia 4.113
EU - Europa 3.711
SA - Sud America 1.101
Continente sconosciuto - Info sul continente non disponibili 358
AF - Africa 159
OC - Oceania 7
AN - Antartide 1
Totale 21.300
Nazione #
US - Stati Uniti d'America 11.532
SG - Singapore 1.639
IT - Italia 1.305
CN - Cina 1.036
BR - Brasile 849
HK - Hong Kong 472
SE - Svezia 471
RU - Federazione Russa 412
DE - Germania 306
FR - Francia 269
VN - Vietnam 251
UA - Ucraina 248
GB - Regno Unito 230
FI - Finlandia 215
IN - India 148
CA - Canada 136
BD - Bangladesh 132
AR - Argentina 72
ID - Indonesia 56
IQ - Iraq 55
CI - Costa d'Avorio 47
MX - Messico 43
TR - Turchia 43
CO - Colombia 41
EC - Ecuador 41
PK - Pakistan 37
VE - Venezuela 36
ES - Italia 35
BE - Belgio 34
PL - Polonia 32
JP - Giappone 29
ZA - Sudafrica 29
NL - Olanda 25
CL - Cile 24
CR - Costa Rica 22
IE - Irlanda 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
PH - Filippine 19
SV - El Salvador 19
IL - Israele 17
LT - Lituania 17
CZ - Repubblica Ceca 16
HN - Honduras 16
MA - Marocco 15
UY - Uruguay 14
AT - Austria 13
GP - Guadalupe 13
GT - Guatemala 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 11
CW - ???statistics.table.value.countryCode.CW??? 11
KR - Corea 11
KZ - Kazakistan 11
MY - Malesia 11
NP - Nepal 11
TT - Trinidad e Tobago 11
IR - Iran 10
JO - Giordania 10
NI - Nicaragua 10
RS - Serbia 10
TW - Taiwan 10
EG - Egitto 9
KE - Kenya 8
PE - Perù 8
PR - Porto Rico 8
PY - Paraguay 8
AU - Australia 7
AZ - Azerbaigian 7
DZ - Algeria 7
JM - Giamaica 7
PA - Panama 7
SC - Seychelles 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
CH - Svizzera 6
NO - Norvegia 6
OM - Oman 6
TH - Thailandia 6
AM - Armenia 5
SN - Senegal 5
AL - Albania 4
BB - Barbados 4
BG - Bulgaria 4
BH - Bahrain 4
ET - Etiopia 4
HR - Croazia 4
PT - Portogallo 4
DK - Danimarca 3
GD - Grenada 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
NG - Nigeria 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
A1 - Anonimo 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
Totale 20.916
Città #
Ashburn 1.259
Fairfield 1.059
Singapore 890
Woodbridge 863
San Jose 774
Chandler 761
Jacksonville 537
Milan 467
Hong Kong 461
Seattle 458
Houston 451
Ann Arbor 407
Cambridge 380
Nyköping 377
Wilmington 354
Beijing 304
Council Bluffs 241
Dallas 220
Bari 175
Los Angeles 166
New York 165
Lawrence 158
Roxbury 157
Rome 151
Nanjing 150
Lauterbourg 149
Santa Clara 115
Des Moines 102
São Paulo 93
Boardman 91
Ho Chi Minh City 87
Princeton 87
Helsinki 80
Inglewood 72
San Diego 60
London 55
Chicago 54
Buffalo 52
Abidjan 47
Brooklyn 45
Munich 45
Shenyang 45
Hanoi 42
Nanchang 37
Figino 36
Frankfurt am Main 36
Brussels 34
Columbus 34
Jakarta 33
Jiaxing 33
Montreal 33
Rio de Janeiro 33
San Francisco 32
Moscow 31
Dong Ket 30
Atlanta 29
Shanghai 28
Baghdad 27
Changsha 26
Phoenix 26
Toronto 26
Warsaw 26
Tianjin 25
Belo Horizonte 24
Hebei 24
North Bergen 23
Denver 22
Turin 22
Orem 21
Tokyo 21
Johannesburg 20
Chennai 19
Dublin 19
Guangzhou 19
Dearborn 17
Dhaka 17
Poplar 17
San José 17
Brasília 16
Charlotte 16
Medellín 16
Mexico City 16
Paris 16
Pune 16
San Salvador 16
Manchester 15
Naples 15
Norwalk 15
Redwood City 15
Quito 14
Tashkent 14
Washington 14
Zhengzhou 14
Falkenstein 13
Lahore 13
Mumbai 13
Nuremberg 13
Stockholm 13
The Dalles 13
Bogotá 12
Totale 13.941
Nome #
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 262
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 242
A novel injectable formulation of 6-Fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson’s disease 241
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 228
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 212
Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+ (BK) channel in the undifferentiated neuroblastoma cells 211
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 210
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels 204
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats 204
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 199
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 196
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 193
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 190
Zoledronic acid modulation of TRPV1 channel currents in osteoblast cell line and native rat and mouse bone marrow-derived osteoblasts: Cell proliferation and mineralization effect 185
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 181
K-ATP channels of rat skeletal muscle fibers: biophysical and pharmacological changes from postnatal development to aging 179
Modulation of K+ channel activity of striated fibers of hypokalemic rats underlies the therapeutical efficacy of minoxidil and acetazolamide. 179
Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in the hypokalemic periodic paralysis 178
Risk of myopathy in patients in therapy with statins: Identification of biological markers in a pilot study 174
Molecular modeling of antibodies for the treatment of TNFα-related immunological diseases 173
Acetazolamide opens the muscular K(Ca)2+ channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis 173
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats 172
Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies 171
Oxytocin/Osteocalcin/IL-6 and NGF/BDNF mRNA Levels in Response to Cold Stress Challenge in Mice: Possible Oxytonic Brain-Bone-Muscle-Interaction 169
Aging and chloride channel regulation in rat fast-twitch muscle fibres 168
The biophysical and pharmacological characteristics of skeletal muscle ATP-Sensitive K+ channels are modified in K+-depleted rat, an animal model of hypokalemic periodic paralysis 166
Cold stress in mice requires Nerve Growth Factor activity in brown fat and increases Osteocalcin expression in bone 166
Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mrna quantitative evaluation and linear correlation analysis 163
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 162
Accelerated infliximab infusion: Safety, factors predicting adverse events, patients' satisfaction and cost analysis. A cohort study in IBD patients 160
The large conductance Ca2+ -activated K+ (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases 159
Antimyotonic actions of new chiral sodium channel, blockers 154
Changes of chloride channel regulation in rat skeletal muscle during aging 151
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 150
Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer 150
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 150
Carboxylic acids and chloride conductance in skeletal muscle: influence on the pharmacological activity induced by the chain substituents and the distance between the phenolic group and the carboxylic function in 4-chloro-phenoxy alkanoic acids 148
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives 148
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 148
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 147
Effects of clofibric acid analogs on chloride channel conductance of rat skeletal muscle 147
Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders 144
Effects of Acetazolamide on alpha subunit of human BK channel expressed in HEK293 cells 143
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 143
NGF-BDNF-Osteocalcin and oxytocin gene interaction in brain, bone, fat stores and reproductive organs 143
A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo 142
Commentary: A BK (Slo1) channel journey from molecule to physiology. 141
Involvement of K(Ca2+)channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle 140
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 139
Oxtr/TRPV1 expression and acclimation of skeletal muscle to cold-stress in male mice 139
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle 138
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 136
Atrophy and phenotype transition signaling exert opposite actions on the KATP channels of disused rat soleus muscle 135
Staurosporine Blocks the ATP-Sensitive K+ Channels and Induces Atrophy in Rodent Skeletal Muscles 135
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties 135
Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects 133
Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes 133
Biophysical changes of skeletal muscle K-ATP channels in K+ depleted rats and pharmacological interventions. 133
ATP sensitive K+ channels of skeletal muscle fibers from K+ depleted rats, an animal model of human HOPP 131
Ion channels in muscle and cardiac hereditary diseases: from gene dysfunction to pharmacological therapy 130
Effects of new K+ channel openers (2H-[1, 4]-benzoxazin-3-one derivatives) on skeletal muscle K-ATP channel. 129
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle 129
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 128
ALTERATIONS OF ELECTRICAL AND BIOCHEMICAL PARAMETERS OF ISCHEMIC AND REPERFUSED RAT SKELETAL-MUSCLE FIBERS 127
Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation 127
Alterazioni delle proprietà biofisiche dei canali al K+ del muscolo scheletrico di ratto prodotte dall'esposizione prenatale a monossido di carbonio 126
Different sulfonylurea and ATP sensitivity characterizes the juvenile and the adult form of K-ATP channel complex of rat skeletal muscle 125
Taurine and skeletal muscle disorders 125
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 124
Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use 124
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 124
Taurine and skeletal muscle ion channels 123
Enantiomeric pairs of clofibric acid analogs produce opposite effects on chloride channel conductance in rat skeletal muscle 123
Effects of mexiletine on ATP sensitive K+ channel of rat skeletal muscle fibres: a state dependent mechanism of action 122
Insulin modulation of ATP-sensitive K+ channel of rat skeletal muscle is impaired in the hypokalaemic state 122
Zoledronic acid as a novel dual blocker of KIR6.1/2-SUR2 subunits of ATP-sensitive K+ channels: Role in the adverse drug reactions 122
Effects of high energy phosphates and l-arginine on the electrical parameters of ischemic-reperfused rat skeletal muscle fibers 121
Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin 120
Expression profile of NGF-BDNF and Osteocalcin genes in brain, bone, fat stores and reproductive organs 120
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 120
Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K(ATP) channel 119
Osteocalcin interacts with Brain-derived Neurotrophic Factor, Nerve Growth Factor but not Oxytocin in the regulation of bone, energy, brain and reproductive functions. 119
Analysis of the introduction in clinical practice of new oral anticoagulants in local health agency bt: Translation of the clinical trial data to a local health care area 119
Biophysical and pharmacological characterization of K-ATP and BK channels of slow and fast rat skeletal muscle fibers 118
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis 118
Developmental changes of membrane electrical properties of rat skeletal muscle fibers produced by prenatal exposure to carbon monoxide 118
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders 118
Approccio multi-target alla terapia medica dell’ipertrofia prostatica benigna 117
A stereospecific bindings site regulates the Cl- ion channel in rat skeletal muscle 117
Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions 115
Antimyotonic actions of new chiral sodium channel blockers 115
Experimental evaluation of the effects of pravastatin on electrophysiological parameters of rat skeletal muscle 115
ATP-sensitive K+ channels of skeletal muscle fibers from young adult and aged rats: Possible involvement of thiol-dependent redox mechanisms in the age-related modifications of their biophysical and pharmacological properties 113
Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II 113
Cysteine restores the activity of ATP-sensitive potassium channels of skeletal muscle fibers of aged rats 112
Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor 111
The KATP channel is a molecular sensor of atrophy in skeletal muscle 111
Stereoselective interaction of tocainide and its chiral analogs with the sodium channels in human myoballs 111
ATP-DEPENDENT EFFECTS OF CROMAKALIM AND OF NEW SYNTHESIZED BENZOXAZINE DERIVATIVES ON MUSCLE KATP CHANNEL. 110
Stereospecific effects of tocainide and its chiral derivatives on rat skeletal muscle sodium channel. 110
Totale 14.756
Categoria #
all - tutte 87.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022932 0 0 0 0 50 69 68 55 121 81 173 315
2022/20231.988 278 207 135 192 252 256 25 214 324 15 53 37
2023/2024745 39 137 43 64 103 150 14 41 25 32 18 79
2024/20252.844 108 46 201 108 93 239 268 293 115 150 380 843
2025/20266.256 830 309 436 604 728 297 727 178 618 529 221 779
2026/20272.081 275 310 502 914 80 0 0 0 0 0 0 0
Totale 21.300